Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Cancer Colorectal”

3,366 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,366 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableLooking for participantsNCT06645236
What this trial is testing

DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
QIAGEN Gaithersburg, Inc 600
Early research (Phase 1)UnknownNCT03189992
What this trial is testing

Study of TCM Syndrome of Hepatocellular Carcinoma and Colorectal Cancer Based on System Science

Who this might be right for
Malignant Tumor of Small Intestine Metastatic to Liver
Shanghai University of Traditional Chinese Medicine 320
Testing effectiveness (Phase 2)Study completedNCT00004911
What this trial is testing

Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionGastric Cancer+4 more
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00003544
What this trial is testing

Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT00610636
What this trial is testing

Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT02780700
What this trial is testing

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 1
Testing effectiveness (Phase 2)Study completedNCT00942292
What this trial is testing

The Effect of Fish Oils on Human Hepatic Colorectal Metastases

Who this might be right for
Colorectal Liver Metastases
University Hospitals, Leicester 20
Not applicableUnknownNCT04525807
What this trial is testing

Precision Medicine for Colorectal Cancer Liver Metastasis Guided by Multi-omics Data Under the Umbrella Theory

Who this might be right for
Colorectal Cancer Metastatic
Fudan University 200
Not applicableStudy completedNCT02322736
What this trial is testing

Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Who this might be right for
Metastatic Colorectal Cancer
Amgen 218
Testing effectiveness (Phase 2)Ended earlyNCT00531115
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 28
Not applicableUnknownNCT04917276
What this trial is testing

Treatment Response Prediction System of mCRC Patients Based on CTC

Who this might be right for
Colorectal Cancer Stage IVCirculating Tumor Cell
Fudan University 100
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Testing effectiveness (Phase 2)Looking for participantsNCT07462650
What this trial is testing

Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticAdenocarcinoma of Colon
Beijing Biotech 48
Large-scale testing (Phase 3)Study completedNCT00384176
What this trial is testing

First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

Who this might be right for
Colorectal Cancer
AstraZeneca 1,814
Not applicableNot Yet RecruitingNCT07754513
What this trial is testing

Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 290
Testing effectiveness (Phase 2)Active Not RecruitingNCT05322590
What this trial is testing

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal CarcinomaNeuropathy
Bexion Pharmaceuticals, Inc. 195
Not applicableLooking for participantsNCT05787197
What this trial is testing

CtDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases

Who this might be right for
Metastatic Colorectal CancerCirculating Tumor DNA
GERCOR - Multidisciplinary Oncology Cooperative Group 232
Early research (Phase 1)Study completedNCT00848510
What this trial is testing

EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases

Who this might be right for
Colorectal and Ovarian Cancer Patients With Liver Metastases
Merck KGaA, Darmstadt, Germany 41
Next Page